Sintetica SA
11
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
9.1%
1 terminated/withdrawn out of 11 trials
90.9%
+4.4% vs industry average
36%
4 trials in Phase 3/4
100%
10 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population
Role: lead
Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population
Role: lead
Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section
Role: lead
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
Role: lead
Efficacy, Safety and Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers
Role: lead
Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia
Role: lead
Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers
Role: lead
Chloroprocaine 2% vs Ropivacaine 0.75% in Ultrasound-guided Axillary Nerve Block
Role: lead
Observational Study on 2-chloroprocaine Hydrochloride 1%
Role: lead
Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures
Role: lead
Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration.
Role: lead
All 11 trials loaded